Skip to content
value.today

DiCE Molecules Holdings, LLC

Total raised
$159 M
4 rounds on record
Latest round
$60 M
Aug 2021
First round on record
Jun 2015
Today
Went public
See the company page

DiCE Molecules Holdings, LLC is listed today as Dice Therapeutics Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of DiCE Molecules Holdings, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2021$60 MNo. 4$50 to $250 million

DiCE Molecules Holdings, LLC: Raise no. 4, Aug 2021

Investors in this round

19 investors had bought by the notice of Sep 7, 2021: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$60 M of $60 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Kevin Judice · Executive Officer, Director
  • Scott Robertson · Executive Officer
  • Jake Simson · Director
  • Jim Scopa · Director
  • Richard Scheller · Director
  • Shaan Gandhi · Director
  • Sharon Tetlow · Director
  • Stephen Zachary · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Judice, Ceo. Newest notice filed Sep 7, 2021. Read the notice at the SEC.

equitySEC
Dec 2020$54 MNo. 3$50 to $250 million

DiCE Molecules Holdings, LLC: Raise no. 3, Dec 2020

Investors in this round

27 investors had bought by the notice of Jan 22, 2021: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$54 M of $82 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Kevin Judice · Executive Officer, Director
  • Scott Robertson · Executive Officer
  • Jake Simson · Director
  • Jim Scopa · Director
  • Richard Scheller · Director
  • Shaan Gandhi · Director
  • Sharon Tetlow · Director
  • Stephen Zachary · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • SVB Leerink LLC (CRD 39011) · Boston, MassachusettsSold in all US states

Signed by Kevin Judice, Ceo. Newest notice filed Jan 22, 2021. Read the notice at the SEC.

equitySEC
Jul 2018$40 MNo. 2$10 to $50 million

DiCE Molecules Holdings, LLC: Raise no. 2, Jul 2018

Investors in this round

19 investors had bought by the notice of Jul 25, 2018: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $60 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Kevin Judice · Executive Officer, Director
  • Scott Robertson · Executive Officer
  • John Bedbrook · Director
  • Michael Rubin · Director
  • Pehr Harbury · Director
  • Phillip Patten · Director
  • Richard Scheller · Director
  • Stephen Zachary · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • JMP Group LLC (CRD 22208) · San Francisco, CaliforniaSold in AR, CA, CT, DC, FL, IL, IN, MA, MD, MN, MO, NC, NJ, NY, PA, TX, VA, WA, and outside the US

Signed by Kevin Judice, Ceo. Newest notice filed Jul 25, 2018. Read the notice at the SEC.

equitySEC
Jun 2015$4 MNo. 1$2 to $10 million

DiCE Molecules Holdings, LLC: Raise no. 1, Jun 2015

Investors in this round

11 investors had bought by the notice of Jun 18, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Kevin Judice · Executive Officer, Promoter
  • Michael Rabson · Executive Officer, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Judice, Ceo. Newest notice filed Jun 18, 2015. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • DiCE Molecules Holdings, LLC chose not to state its revenue in its newest notice of a funding round (Sep 2021).

    SEC Form D · Sep 2021

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Sep 2021

Products and services#

No products or services of DiCE Molecules Holdings, LLC are on record.

Investors#

No investor of DiCE Molecules Holdings, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by DiCE Molecules Holdings, LLC
NameRoleNamed in
Kevin JudiceExecutive officerSep 2021
Scott RobertsonExecutive officerSep 2021
Michael RabsonExecutive officerJun 2015
Jake SimsonDirectorSep 2021
Jim ScopaDirectorSep 2021
Kevin JudiceDirectorSep 2021
Richard SchellerDirectorSep 2021
Shaan GandhiDirectorSep 2021
Sharon TetlowDirectorSep 2021
Stephen ZacharyDirectorSep 2021
John BedbrookDirectorJul 2018
Michael RubinDirectorJul 2018
Pehr HarburyDirectorJul 2018
Phillip PattenDirectorJul 2018
Kevin JudicePromoterJun 2015
Michael RabsonPromoterJun 2015

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.